PAR NAMES CEO TO LEAD TRANSITION TO BRANDED DRUGS

Par Pharmaceutical Cos., a generic-drug maker being scrutinized by U.S. regulators, said Tuesday that it named Patrick G. LePore, 51, as president and chief executive officer to replace Scott Tarriff, 47, who was fired.

NorthJersey.com (http://www.northjersey.com/page.php?qstr=eXJpcnk3ZjczN2Y3dnFlZUVFeXkyOSZmZ2JlbDdmN3ZxZWVFRXl5Njk5NzM4NyZ5cmlyeTdmNzE3Zjd2cWVlRUV5eTI=)